After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Merus N.V is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Merus N.V is $2.61B. A total of 0.82 million shares were traded on the day, compared to an average of 603.00K shares.
In the most recent transaction, Shuman Harry sold 115 shares of MRUS for 26.68 per share on Dec 19 ’23. After the transaction, the VP Controller, PAO now owns 7,002 company shares. In a previous transaction on Dec 15 ’23, Silverman Peter B. sold 22,386 shares at 25.00 per share. MRUS shares that COO & GC owns now total 0.
Among the insiders who sold shares, Shuman Harry disposed of 250 shares on Dec 08 ’23 at a per-share price of $24.44. This resulted in the VP Controller, PAO holding 7,117 shares of MRUS after the transaction. In another insider transaction, Shuman Harry sold 575 shares at $24.58 per share on Dec 01 ’23. Company shares held by the VP Controller, PAO now total 7,367.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, MRUS has a high of $52.03 and a low of $18.21.
As of this writing, MRUS has an earnings estimate of -$0.81 per share for the current quarter. EPS was calculated based on a consensus of 12.0 estimates, with a high estimate of -$0.61 per share and a lower estimate of -$1.09. The company reported an EPS of -$0.86 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. MRUS’s latest balance sheet shows that the firm has $410.43M in Cash & Short Term Investments as of fiscal 2021. There were $3.75M in debt and $71.90M in liabilities at the time. Its Book Value Per Share was $6.16, while its Total Shareholder’s Equity was $316.20M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MRUS is Buy with a score of 4.92.
